Drugs / MORRHUATE SODIUM
MORRHUATE SODIUM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01897259 | Mar 2012 → Jun 2019 | epicondylitis | Christine M. Kleinert Institute for Hand and Microsurgery | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MORRHUATE SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109139 ↗ |
| Known as | Morrhuate de sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109139 ↗ |
| Known as | Morruato de sodio | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109139 ↗ |
| Known as | Sodium Morrhuate | “Subjects participating in the prolotherapy group will recieve 1 cc 50% Dextrose and Sodium Morrhuate 1 cc injections.” NCT01897259 ↗ |